1
|
Fertitta L, Bergqvist C, Armand ML, Moryousef S, Ferkal S, Jannic A, Ravaud P, Tran VT, Ezzedine K, Wolkenstein P. Quality of life in neurofibromatosis 1: development and validation of a tool dedicated to cutaneous neurofibromas in adults. J Eur Acad Dermatol Venereol 2022; 36:1359-1366. [PMID: 35412677 DOI: 10.1111/jdv.18140] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2021] [Revised: 02/10/2022] [Accepted: 03/14/2022] [Indexed: 11/29/2022]
Abstract
BACKGROUND Cutaneous neurofibromas (cNF), present in 95% of individuals with neurofibromatosis 1 (NF1), are considered as one of the greatest medical burden because of physical disfigurement. No specific score evaluates their impact on quality of life (QoL). OBJECTIVE To develop a specific score assessing cNF-related QoL. METHODS Through a multidisciplinary workshop including 10 patients, 3 expert-in-NF1 physicians, 3 health care workers (nurses and psychologist) and 1 methodologist, the French version of the Skindex-16 was modified by adding 3 items. The new cNF-Skindex was validated among patients with NF1 recruited in the ComPaRe online cohort, in France (N=284). Construct validity was assessed by comparing it with the EQ-5D-5L, its visual analog scale and the MYMOP2 and by assessing its association with patients' characteristics. Reliability was assessed by a test-retest. An English version of the tool was developed using a back forward translation. RESULTS A total of 228 individuals with NF1, with cNF answered the 19-item questionnaire. These items fitted into 3 domains: emotions, symptoms, functioning. One was dropped during analysis because >90% responders were not concerned. The cNF-Skindex significantly correlated with the EQ-5D-5L (N=193) and MYMOP2 (N=210) indicating good external validity: rs 0.38 (p<0.001), and 0.58 (p<0.001) respectively. Having >50 cNF was the only independent variable associated with the total score cNF-Skindex (β=15.88, 95%CI 6.96 - 24.81, p=0.001), and with the 3 sub-scores: "functioning" (β=2.65, 95%CI 0.71 - 4.59, p=0.008), "emotions" (β=17.03, 95%CI 4.11 - 29.96, p=0.010) and "symptoms" (β=3.90, 95%CI 1.95 - 5.85, p<0.001). Test-retest reliability (N=133) found an ICC at 0.96 demonstrating good reproducibility. CONCLUSION The cNF-Skindex demonstrated excellent psychometric properties. The global and sub-scores were increased with higher number of cNF arguing for its use in further trials aiming to reduce their number or prevent their development. Cross-cultural validation and evaluation of its responsiveness are the next steps.
Collapse
Affiliation(s)
- L Fertitta
- Dept. of Dermatology, National Referral Center for Neurofibromatoses, Henri Mondor Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), 94010, Créteil, France
| | - C Bergqvist
- Dept. of Dermatology, National Referral Center for Neurofibromatoses, Henri Mondor Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), 94010, Créteil, France
| | - M L Armand
- Dept. of Dermatology, National Referral Center for Neurofibromatoses, Henri Mondor Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), 94010, Créteil, France
| | - S Moryousef
- Dept. of Dermatology, National Referral Center for Neurofibromatoses, Henri Mondor Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), 94010, Créteil, France
| | - S Ferkal
- Dept. of Dermatology, National Referral Center for Neurofibromatoses, Henri Mondor Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), 94010, Créteil, France.,INSERM, Centre d'Investigation Clinique 1430, National Referral Center for Neurofibromatoses, Henri-Mondor Hospital, Assistance Publique-Hôpitaux Paris (AP-HP), 94010, Créteil, France
| | - A Jannic
- Dept. of Dermatology, National Referral Center for Neurofibromatoses, Henri Mondor Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), 94010, Créteil, France
| | - P Ravaud
- Center for Clinical Epidemiology, Hôtel-Dieu Hospital (AP-HP), Paris, France.,Université de Paris, CRESS, INSERM, INRA, F-75004, Paris, France
| | - V T Tran
- Center for Clinical Epidemiology, Hôtel-Dieu Hospital (AP-HP), Paris, France.,Université de Paris, CRESS, INSERM, INRA, F-75004, Paris, France
| | - K Ezzedine
- Dept. of Dermatology, National Referral Center for Neurofibromatoses, Henri Mondor Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), 94010, Créteil, France.,Université Paris-Est Créteil (UPEC), 94010, Créteil, France
| | - P Wolkenstein
- Dept. of Dermatology, National Referral Center for Neurofibromatoses, Henri Mondor Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), 94010, Créteil, France.,Université Paris-Est Créteil (UPEC), 94010, Créteil, France.,INSERM U955, 94010, Créteil, France
| |
Collapse
|
2
|
Bergqvist C, Fertitta L, Ezzedine K, Jannic A, Zehou O, Ferkal S, Combemale P, Barbarot S, Mazereeuw‐Hautier J, Sbidian E, Wolkenstein P, France NF. Identification of three clinical neurofibromatosis 1 subtypes: Latent class analysis of a series of 1,351 patients. J Eur Acad Dermatol Venereol 2022; 36:739-743. [DOI: 10.1111/jdv.17974] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2021] [Revised: 12/08/2021] [Accepted: 01/07/2022] [Indexed: 12/01/2022]
Affiliation(s)
- C. Bergqvist
- Department of Dermatology National Referral Center for Neurofibromatoses Henri‐Mondor Hospital Assistance Publique‐Hôpital Paris (AP‐HP) Créteil France
| | - L. Fertitta
- Department of Dermatology National Referral Center for Neurofibromatoses Henri‐Mondor Hospital Assistance Publique‐Hôpital Paris (AP‐HP) Créteil France
| | - K. Ezzedine
- Department of Dermatology National Referral Center for Neurofibromatoses Henri‐Mondor Hospital Assistance Publique‐Hôpital Paris (AP‐HP) Créteil France
- Faculty of Medicine Université Paris‐Est Créteil (UPEC) Créteil France
| | - A. Jannic
- Department of Dermatology National Referral Center for Neurofibromatoses Henri‐Mondor Hospital Assistance Publique‐Hôpital Paris (AP‐HP) Créteil France
| | - O. Zehou
- Department of Dermatology National Referral Center for Neurofibromatoses Henri‐Mondor Hospital Assistance Publique‐Hôpital Paris (AP‐HP) Créteil France
| | - S. Ferkal
- Department of Dermatology National Referral Center for Neurofibromatoses Henri‐Mondor Hospital Assistance Publique‐Hôpital Paris (AP‐HP) Créteil France
- INSERM Centre d’Investigation Clinique 1430 Assistance Publique‐Hôpital Paris (AP‐HP) Henri‐Mondor Hospital Créteil France
| | - P. Combemale
- Department of Dermatology Centre Léon Bérard Lyon France
| | - S. Barbarot
- Dermatology Department Nantes Université University hospital of Nantes UMR INRAE 1280 PhAN Nantes France
| | - J. Mazereeuw‐Hautier
- Department of Dermatology Referral Centre for Rare Skin Diseases Toulouse University Hospital Toulouse France
| | - E. Sbidian
- Department of Dermatology National Referral Center for Neurofibromatoses Henri‐Mondor Hospital Assistance Publique‐Hôpital Paris (AP‐HP) Créteil France
- Faculty of Medicine Université Paris‐Est Créteil (UPEC) Créteil France
| | - P. Wolkenstein
- Department of Dermatology National Referral Center for Neurofibromatoses Henri‐Mondor Hospital Assistance Publique‐Hôpital Paris (AP‐HP) Créteil France
- Faculty of Medicine Université Paris‐Est Créteil (UPEC) Créteil France
- INSERM U955 Neurofibromatosis and Lymphoma oncogenesis Créteil France
| | - NF France
- Department of Dermatology National Referral Center for Neurofibromatoses Henri‐Mondor Hospital Assistance Publique‐Hôpital Paris (AP‐HP) Créteil France
| |
Collapse
|
3
|
Fertitta L, Bolling M, Vargas R, van den Akker P, Bourrat E, van Geel M, Knebelmann B, Leclerc-Mercier S, Houillier P, Hadj-Rabia S. 085 Hypohidrosis, ichthyosis and hypokalemia: HELIX syndrome. J Invest Dermatol 2021. [DOI: 10.1016/j.jid.2021.08.087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
4
|
Andina D, Belloni‐Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I, Diociaiuti A, El‐Hachem M, Fertitta L, Gysel D, Hernández‐Martín A, Hubiche T, Luca C, Martos‐Cabrera L, Maruani A, Mazzotta F, Akkaya AD, Casals M, Ferrando J, Grimalt R, Grozdev I, Kinsler V, Morren MA, Munisami M, Nanda A, Novoa MP, Ott H, Pasmans S, Salavastru C, Zawar V, Torrelo A. Skin manifestations of COVID-19 in children: Part 2. Clin Exp Dermatol 2021; 46:451-461. [PMID: 33166429 PMCID: PMC9275399 DOI: 10.1111/ced.14482] [Citation(s) in RCA: 31] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2020] [Accepted: 08/13/2020] [Indexed: 01/09/2023]
Abstract
The current COVID-19 pandemic is caused by the SARS-CoV-2 coronavirus. The initial recognized symptoms were respiratory, sometimes culminating in severe respiratory distress requiring ventilation, and causing death in a percentage of those infected. As time has passed, other symptoms have been recognized. The initial reports of cutaneous manifestations were from Italian dermatologists, probably because Italy was the first European country to be heavily affected by the pandemic. The overall clinical presentation, course and outcome of SARS-CoV-2 infection in children differ from those in adults, as do the cutaneous manifestations of childhood. In this review, we summarize the current knowledge on the cutaneous manifestations of COVID-19 in children after thorough and critical review of articles published in the literature and from the personal experience of a large panel of paediatric dermatologists in Europe. In Part 1, we discussed one of the first and most widespread cutaneous manifestations of COVID-19, chilblain-like lesions. In this part of the review, we describe other manifestations, including erythema multiforme, urticaria and Kawasaki disease-like inflammatory multisystemic syndrome. In Part 3, we discuss the histological findings of COVID-19 manifestations, and the testing and management of infected children for both COVID-19 and any other pre-existing conditions.
Collapse
Affiliation(s)
- D. Andina
- Department of Dermatology Hospital Infantil Universitario Niño Jesús Madrid
Spain
| | - A. Belloni‐Fortina
- Pediatric Dermatology Unit Department of Medicine DIMED University of Padua
Padua Italy
| | - C. Bodemer
- Department of Dermatology Hospital Necker Enfants MaladesParis Centre
University Paris France
| | - E. Bonifazi
- Dermatologia Pediatrica Association Bari Italy
| | | | - I. Colmenero
- Department of Pathology Hospital Infantil Universitario Niño Jesús Madrid
Spain
| | - A. Diociaiuti
- Dermatology Unit Bambino Gesù Children’s HospitalIRCCS Rome
Italy
| | - M. El‐Hachem
- Dermatology Unit Bambino Gesù Children’s HospitalIRCCS Rome
Italy
| | - L. Fertitta
- Department of Dermatology Hospital Necker Enfants MaladesParis Centre
University Paris France
| | - D. Gysel
- Department of Pediatrics O. L. Vrouw Hospital Aalst Belgium
| | - A. Hernández‐Martín
- Department of Dermatology Hospital Infantil Universitario Niño Jesús Madrid
Spain
| | - T. Hubiche
- Department of Dermatology Université Côte d'Azur Nice France
| | - C. Luca
- Nicolina Medical Center Iasi Romania
| | - L. Martos‐Cabrera
- Department of Dermatology Hospital Infantil Universitario Niño Jesús Madrid
Spain
| | - A. Maruani
- Department of Dermatology Unit of Pediatric Dermatology University of
ToursSPHERE‐INSERM1246, CHRU Tours Tours France
| | - F. Mazzotta
- Dermatologia Pediatrica Association Bari Italy
| | - A. D. Akkaya
- Department of Dermatology Ulus Liv Hospital Istanbul Turkey
| | - M. Casals
- Department of Dermatology Hospital Universitari de Sabadell Barcelona
Spain
| | - J. Ferrando
- Department of Dermatology Hospital Clìnic Barcelona Spain
| | - R. Grimalt
- Faculty of Medicine and Health Sciences Universitat Internacional de
Catalunya Barcelona Spain
| | - I. Grozdev
- Department of Dermatology Children's University Hospital Queen Fabiola
Brussels Belgium
| | - V. Kinsler
- Department of Paediatric Dermatology Great Ormond Street Hospital for
Children NHS Foundation Trust London UK
| | - M. A. Morren
- Pediatric Dermatology Unit Department of Pediatrics and Dermato‐Venereology
University Hospital Lausanne and University of Lausanne Lausanne
Switzerland
| | - M. Munisami
- Department of Dermatology and Sexually Transmitted Diseases Jawaharlal
Institute of Postgraduate Medical Education and Research (JIPMER) Puducherry
India
| | - A. Nanda
- As'ad Al‐Hamad Dermatology Center Kuwait City Kuwait
| | - M. P. Novoa
- Department of Dermatology Hospital San Jose Bogota Colombia
| | - H. Ott
- Division of Pediatric Dermatology Children’s Hospital Auf der Bult Hannover
Germany
| | - S. Pasmans
- Erasmus MC University Medical Center RotterdamSophia Children's Hospital
Rotterdam The Netherlands
| | - C. Salavastru
- Department of Paediatric Dermatology Colentina Clinical HospitalCarol
Davila University of Medicine and Pharmacy Bucharest Romania
| | - V. Zawar
- Department of Dermatology Dr Vasantrao Pawar Medical College Nashik
India
| | - A. Torrelo
- Correspondence: Dr Antonio Torrelo, Department of Dermatology, Hospital
Niño Jesús, Menendez Pelayo 65, Madrid 28034, Spain E‐mail:
| | | |
Collapse
|
5
|
Hubiche T, Phan A, Leducq S, Rapp J, Fertitta L, Aubert H, Barbarot S, Chiaverini C, Giraudeau B, Lasek A, Mallet S, Labarelle A, Piram M, McCuaig C, Martin L, Monitor L, Nicol I, Bissuel M, Bellissen A, Jullien D, Lesort C, Vabres P, Maruani A. Acute acral eruptions in children during the COVID-19 pandemic: Characteristics of 103 children and their family clusters. Ann Dermatol Venereol 2021; 148:94-100. [PMID: 33551211 PMCID: PMC7831537 DOI: 10.1016/j.annder.2020.11.005] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2020] [Revised: 10/15/2020] [Accepted: 11/26/2020] [Indexed: 12/20/2022]
Abstract
Background A marked increase in frequency of acute acral eruptions (AAE) was observed in children during the COVID-19 pandemic in the spring period. Objectives In this observational multicenter study, based on children with AAE, we aimed to assess the proportion of household members possibly infected by SARS-CoV-2. Methods We collected data from all children observed with AAE, prospectively from April 7, 2020 to June 22, 2020, and retrospectively since February 28, 2020. The primary outcome was the household infection rate, defined as the proportion of family clusters having at least one member with COVID-19 infection other than the child with AAE (“index child”). The definition of a case was based on characteristic clinical signs and a positive PCR or serology. Results The study included 103 children in 10 French departments and in Quebec. The median age was 13 years and the interquartile range [8–15], with a female-to-male ratio of 1/1.15. In children with AAE, all PCR tests were negative (n = 18), and serology was positive in 2/14 (14.3%) cases. We found no significant anomalies in the lab results. A total of 66 of the 103 families (64.1%) of included children had at least one other infected member apart from the index child. The total number of household members was 292, of whom 119 (40.8%) were considered possibly infected by SARS-CoV-2. No index children or households exhibited severe COVID-19. Discussion Among the 103 households included, 64.1% had at least one infected member. Neither children with AAE nor their households showed severe COVID-19.
Collapse
Affiliation(s)
- T Hubiche
- Nice University Hospital, Department of Dermatology, 06000 Nice, France
| | - A Phan
- Lyon University Hospital, Department of Pediatric Dermatology, Hospices Civils de Lyon, 69500 Bron, France
| | - S Leducq
- Universities of Tours and Nantes, inserm 1246-SPHERE, 37000 Tours, France; Tours University Hospital, Department of Dermatology, 37044 Tours Cedex 9, France
| | - J Rapp
- Nice University Hospital, Department of Dermatology, 06000 Nice, France
| | - L Fertitta
- AP-HP (Paris Hospitals), Paris-Necker Hospital, Department of Dermatology, 75015 Paris, France
| | - H Aubert
- Nantes University Hospital, Department of Dermatology, 44000 Nantes, France
| | - S Barbarot
- Nantes University Hospital, Department of Dermatology, 44000 Nantes, France
| | - C Chiaverini
- Nice University Hospital, Department of Dermatology, 06000 Nice, France
| | - B Giraudeau
- Universities of Tours and Nantes, inserm 1246-SPHERE, 37000 Tours, France; Tours University Hospital, Clinical Investigation Center-INSERM 1415, 37000 Tours, France
| | - A Lasek
- Saint Vincent de Paul Hospital, Université catholique de Lille, 59000 Lille, France
| | - S Mallet
- Marseille University Hospital, Department of Dermatology, 13000 Marseille, France
| | - A Labarelle
- Marseille University Hospital, Department of Dermatology, 13000 Marseille, France
| | - M Piram
- Sainte-Justine University Hospital, Division of Dermatology, Montreal, Quebec, Canada
| | - C McCuaig
- Sainte-Justine University Hospital, Division of Dermatology, Montreal, Quebec, Canada
| | - L Martin
- Angers Hospital University, Department of Dermatology, 49000 Angers, France
| | - L Monitor
- Nancy University Hospital, Department of Dermatology, 54511 Vandœuvre-lès-Nancy, France
| | - I Nicol
- Marseille University Hospital, Department of Dermatology, 13000 Marseille, France
| | - M Bissuel
- Casamance Private Hospital, Department of Pediatrics, 13400 Aubagnes, France
| | - A Bellissen
- Marseille University Hospital, Department of Dermatology, 13000 Marseille, France
| | - D Jullien
- Lyon University Hospital, Department of Dermatology, Hospital Edouard Herriot, 69003 Lyon, France
| | - C Lesort
- Lyon University Hospital, Department of Dermatology, Hospital Edouard Herriot, 69003 Lyon, France
| | - P Vabres
- Dijon University Hospital, Department of Dermatology, 21000 Dijon, France
| | - A Maruani
- Universities of Tours and Nantes, inserm 1246-SPHERE, 37000 Tours, France; Tours University Hospital, Department of Dermatology, 37044 Tours Cedex 9, France; Tours University Hospital, Clinical Investigation Center-INSERM 1415, 37000 Tours, France.
| | | |
Collapse
|
6
|
Hubiche T, Phan A, Leducq S, Rapp J, Fertitta L, Aubert H, Barbarot S, Chiaverini C, Giraudeau B, Labarelle A, Mc Craig C, Martin L, Monitor L, Nicol I, Piram M, Bissuel M, Bellissen A, Lasek A, Mallet S, Vabres P, Maruani A. Acrosyndromes aigus pédiatriques au cours de l’épidémie de COVID-19 : étude des caractéristiques de la cellule familiale. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.100] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
7
|
Fertitta L, Welfringer A, Polivka L, Chhun S, Ouedrani A, Chatenoud L, Hadj-Rabia S, Sermet-Gaudelus I, Bodemer C. Pseudo-engelures de l’enfant et SARS-CoV-2 : quel lien ? Ann Dermatol Venereol 2020. [PMCID: PMC7688282 DOI: 10.1016/j.annder.2020.09.235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Introduction L’augmentation des manifestations cutanées acrales pendant l’épidémie de SARS-CoV-2 interroge. Notre objectif était d’analyser un éventuel lien au travers de 3 tests biologiques diagnostiques SARS-CoV-2. Matériel et méthodes Du 08/04 au 03/06/2020 ont été inclus les enfants adressés en consultation de dermatologie pédiatrique pour des manifestations cutanées aiguës, inhabituelles chez le patient, et associées à des symptômes évocateurs de COVID-19 : signes systémiques chez l’enfant et/ou chez un parent au 1er degré, pendant le pic épidémique de SARS-CoV-2. Résultats Trente patients et 37 apparentés symptomatiques au 1er degré étaient inclus. Dix-sept patients présentaient des lésions de pseudo-engelures, survenant après des manifestations systémiques (60 %, délai moyen : 22 j). Une rémission complète était notée chez 11/17 patients dans les 10 à 50 jours. Les autres manifestations cutanées observées étaient des lésions à type de : urticaire parfois linéaire, exanthème maculo-papuleux (EMP), livédo. Parmi les 37 apparentés, des manifestations cutanées étaient observées au cours de la même période : pseudo-engelures (n = 3 ; 37 %), EMP (n = 3 ; 37 %), urticaires (n = 3 ; 37 %). Un syndrome inflammatoire était présent chez 11/30 enfants (37 %) dont 8/17 avec pseudo-engelures (47 %) : élévation de CRP et/ou élévation des concentrations de cytokines inflammatoires. Parmi les 17 patients avec pseudo-engelures, 8 avaient des concentrations sériques d’IL-1, IL-6, TNF-α ou IFN de type 1 augmentées, et ce parfois plusieurs semaines après les manifestations systémiques. Les 3 PCR nasales réalisées chez les patients symptomatiques (fièvre ou toux) étaient négatives. Parmi les 16/17 patients avec pseudo-engelures prélevés, un seul avait une sérologie SARS-CoV-2 positive (IgG, technique Abbott ARCHITECT®). Des explorations immunologiques complémentaires témoignant d’un contact direct avec le virus (dont ELISPOT®) sont en cours de vérification de résultats. Discussion Tous les patients, sauf un, avaient des tests négatifs pour le SARS-CoV-2. L’élévation persistante d’IL-1 et de la CRP pourrait refléter une réaction immunologique post-virale intense. Malgré l’absence de détection du SARS-CoV-2, les données épidémiologiques, les manifestations cliniques évocatrices et l’élévation des cytokines chez nos patients suggèrent un lien entre ce virus et les manifestations cutanées motivant la poursuite des explorations immunologiques.
Collapse
|
8
|
Fertitta L, Winter S, Castelle M, Hadj-Rabia S, Fraitag S, Bodemer C. Erythrodermie du nourrisson : quand évoquer un déficit immunitaire ? Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
9
|
Andina D, Belloni-Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I, Diociaiuti A, El-Hachem M, Fertitta L, van Gysel D, Hernández-Martín A, Hubiche T, Luca C, Martos-Cabrera L, Maruani A, Mazzotta F, Akkaya AD, Casals M, Ferrando J, Grimalt R, Grozdev I, Kinsler V, Morren MA, Munisami M, Nanda A, Novoa MP, Ott H, Pasmans S, Salavastru C, Zawar V, Torrelo A. Skin manifestations of COVID-19 in children: Part 3. Clin Exp Dermatol 2020; 46:462-472. [PMID: 33207021 PMCID: PMC7753282 DOI: 10.1111/ced.14483] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2020] [Accepted: 08/13/2020] [Indexed: 12/13/2022]
Abstract
The current COVID‐19 pandemic is caused by the SARS‐CoV‐2 coronavirus. The initial
recognized symptoms were respiratory, sometimes culminating in severe respiratory distress
requiring ventilation, and causing death in a percentage of those infected. As time has
passed, other symptoms have been recognized. The initial reports of cutaneous
manifestations were from Italian dermatologists, probably because Italy was the first
European country to be heavily affected by the pandemic. The overall clinical
presentation, course and outcome of SARS‐CoV‐2 infection in children differ from those in
adults as do the cutaneous manifestations of childhood. In this review, we summarize the
current knowledge on the cutaneous manifestations of COVID‐19 in children after thorough
and critical review of articles published in the literature and from the personal
experience of a large panel of paediatric dermatologists in Europe. In Part 1, we discuss
one of the first and most widespread cutaneous manifestations of COVID‐19, chilblain‐like
lesions, and in Part 2 we expanded to other manifestations, including erythema multiforme,
urticaria and Kawasaki disease‐like inflammatory multisystemic syndrome. In this part of
the review, we discuss the histological findings of COVID‐19 manifestations, and the
testing and management of infected children for both COVID‐19 and any other pre‐existing
conditions. Click here for the corresponding questions to this CME article.
Collapse
Affiliation(s)
- D Andina
- Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
| | - A Belloni-Fortina
- Pediatric Dermatology Unit, Department of Medicine DIMED, University of Padua, Padua, Italy
| | - C Bodemer
- Department of Dermatology, Hospital Necker Enfants Malades, Paris Centre University, Paris, France
| | - E Bonifazi
- Dermatologia Pediatrica Association, Bari, Italy
| | - A Chiriac
- Nicolina Medical Center, Iasi, Romania
| | - I Colmenero
- Department of Pathology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
| | - A Diociaiuti
- Dermatology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - M El-Hachem
- Dermatology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - L Fertitta
- Department of Dermatology, Hospital Necker Enfants Malades, Paris Centre University, Paris, France
| | - D van Gysel
- Department of Pediatrics, O. L. Vrouw Hospital, Aalst, Belgium
| | - A Hernández-Martín
- Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
| | - T Hubiche
- Department of Dermatology, Université Côte d'Azur, Nice, France
| | - C Luca
- Nicolina Medical Center, Iasi, Romania
| | - L Martos-Cabrera
- Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
| | - A Maruani
- Department of Dermatology, Unit of Pediatric Dermatology, University of Tours, SPHERE-INSERM1246, CHRU Tours, Tours, France
| | - F Mazzotta
- Dermatologia Pediatrica Association, Bari, Italy
| | - A D Akkaya
- Department of Dermatology, Ulus Liv Hospital, Istanbul, Turkey
| | - M Casals
- Department of Dermatology, Hospital Universitari de Sabadell, Barcelona, Spain
| | - J Ferrando
- Department of Dermatology, Hospital Clìnic, Barcelona, Spain
| | - R Grimalt
- Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain
| | - I Grozdev
- Department of Dermatology, Children's University Hospital Queen Fabiola, Brussels, Belgium
| | - V Kinsler
- Department of Paediatric Dermatology, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, UK
| | - M A Morren
- Pediatric Dermatology Unit, Department of Pediatrics and Dermato-Venereology, University Hospital Lausanne and University of Lausanne, Lausanne, Switzerland
| | - M Munisami
- Department of Dermatology and Sexually Transmitted Diseases, Jawaharlal Institute Of Postgraduate Medical Education and Research (JIPMER), Puducherry, India
| | - A Nanda
- As'ad Al-Hamad Dermatology Center, Kuwait City, Kuwait
| | - M P Novoa
- Department of Dermatology, Hospital San Jose, Bogota, Colombia
| | - H Ott
- Division of Pediatric Dermatology, Children's Hospital Auf der Bult, Hannover, Germany
| | - S Pasmans
- Erasmus MC University Medical Center Rotterdam, Sophia Children's Hospital, Rotterdam, The Netherlands
| | - C Salavastru
- Department of Paediatric Dermatology, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| | - V Zawar
- Department of Dermatology, Dr Vasantrao Pawar Medical College, Nashik, India
| | - A Torrelo
- Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
| | | |
Collapse
|
10
|
Andina D, Belloni-Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I, Diociaiuti A, El-Hachem M, Fertitta L, van Gysel D, Hernández-Martín A, Hubiche T, Luca C, Martos-Cabrera L, Maruani A, Mazzotta F, Akkaya AD, Casals M, Ferrando J, Grimalt R, Grozdev I, Kinsler V, Morren MA, Munisami M, Nanda A, Novoa MP, Ott H, Pasmans S, Salavastru C, Zawar V, Torrelo A. Skin manifestations of COVID-19 in children: Part 1. Clin Exp Dermatol 2020; 46:444-450. [PMID: 33180982 PMCID: PMC9275402 DOI: 10.1111/ced.14481] [Citation(s) in RCA: 36] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2020] [Accepted: 08/13/2020] [Indexed: 01/08/2023]
Abstract
The current COVID‐19 pandemic is caused by the SARS‐CoV‐2 coronavirus. The initial
recognized symptoms were respiratory, sometimes culminating in severe respiratory distress
requiring ventilation, and causing death in a percentage of those infected. As time has
passed, other symptoms have been recognized. The initial reports of cutaneous
manifestations were from Italian dermatologists, probably because Italy was the first
European country to be heavily affected by the pandemic. The overall clinical
presentation, course and outcome of SARS‐CoV‐2 infection in children differ from those in
adults as do the cutaneous manifestations of childhood. In this review, we summarize the
current knowledge on the cutaneous manifestations of COVID‐19 in children after thorough
and critical review of articles published in the literature and from the personal
experience of a large panel of paediatric dermatologists in Europe. In Part 1, we discuss
one of the first and most widespread cutaneous manifestation of COVID‐19, chilblain‐like
lesions. In Part 2, we review other manifestations, including erythema multiforme,
urticaria and Kawasaki disease‐like inflammatory multisystemic syndrome, while in Part 3,
we discuss the histological findings of COVID‐19 manifestations, and the testing and
management of infected children, for both COVID‐19 and any other pre‐existing
conditions. Click here for the corresponding questions to this CME article.
Collapse
Affiliation(s)
- D Andina
- Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
| | - A Belloni-Fortina
- Pediatric Dermatology Unit, Department of Medicine DIMED, University of Padua, Padua, Italy
| | - C Bodemer
- Department of Dermatology, Hospital Necker Enfants Malades, Paris Centre University, Paris, France
| | - E Bonifazi
- Dermatologia Pediatrica Association, Bari, Italy
| | - A Chiriac
- Nicolina Medical Center, Iasi, Romania
| | - I Colmenero
- Department of Pathology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
| | - A Diociaiuti
- Dermatology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - M El-Hachem
- Dermatology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - L Fertitta
- St Parascheva Infectious Diseases Hospital, Iasi, Romania
| | - D van Gysel
- Department of Pediatrics, O. L. Vrouw Hospital, Aalst, Belgium
| | - A Hernández-Martín
- Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
| | - T Hubiche
- Department of Dermatology, Université Côte d'Azur, Nice, France
| | - C Luca
- Nicolina Medical Center, Iasi, Romania
| | - L Martos-Cabrera
- Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
| | - A Maruani
- Department of Dermatology, Unit of Pediatric Dermatology, University of Tours, SPHERE-INSERM1246, CHRU Tours, Tours, France
| | - F Mazzotta
- Dermatologia Pediatrica Association, Bari, Italy
| | - A D Akkaya
- Department of Dermatology, Ulus Liv Hospital, Istanbul, Turkey
| | - M Casals
- Department of Dermatology, Hospital Universitari de Sabadell, Barcelona, Spain
| | - J Ferrando
- Department of Dermatology, Hospital Clìnic, Barcelona, Spain
| | - R Grimalt
- Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain
| | - I Grozdev
- Department of Dermatology, Children's University Hospital Queen Fabiola, Brussels, Belgium
| | - V Kinsler
- Department of Paediatric Dermatology, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, UK
| | - M A Morren
- Pediatric Dermatology Unit, Department of Pediatrics and Dermato-Venereology, University Hospital Lausanne and University of Lausanne, Lausanne, Switzerland
| | - M Munisami
- Department of Dermatology and Sexually Transmitted Diseases, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India
| | - A Nanda
- As'ad Al-Hamad Dermatology Center, Kuwait City, Kuwait
| | - M P Novoa
- Department of Dermatology, Hospital San Jose, Bogota, Colombia
| | - H Ott
- Division of Pediatric Dermatology, Children's Hospital Auf der Bult, Hannover, Germany
| | - S Pasmans
- Erasmus MC University Medical Center Rotterdam, Sophia Children's Hospital, Rotterdam, The Netherlands
| | - C Salavastru
- Department of Paediatric Dermatology, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| | - V Zawar
- Department of Dermatology, Dr Vasantrao Pawar Medical College, Nashik, India
| | - A Torrelo
- Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
| | | |
Collapse
|
11
|
Fertitta L, Welfringer-Morin A, Ouedrani A, Polivka L, Chhun S, Chatenoud L, Fourgeaud J, Hadj-Rabia S, Temmam S, Eloit M, Sermet-Gaudelus I, Bodemer C. Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2. J Eur Acad Dermatol Venereol 2020; 35:e164-e167. [PMID: 33010072 PMCID: PMC7675551 DOI: 10.1111/jdv.16972] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Affiliation(s)
- L Fertitta
- Department of Dermatology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.,Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France
| | - A Welfringer-Morin
- Department of Dermatology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.,Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France
| | - A Ouedrani
- Institut Necker-Enfants Malades, Université de Paris, Paris, France.,Laboratory of Immunology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France
| | - L Polivka
- Department of Dermatology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.,Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France
| | - S Chhun
- Institut Necker-Enfants Malades, Université de Paris, Paris, France.,Laboratory of Immunology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France
| | - L Chatenoud
- Institut Necker-Enfants Malades, Université de Paris, Paris, France.,Laboratory of Immunology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France
| | - J Fourgeaud
- Laboratory of Virology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France
| | - S Hadj-Rabia
- Department of Dermatology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.,Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.,INSERM U1163, Institut Imagine, Hôpital Universitaire Necker-Enfants Malades, Paris, France
| | - S Temmam
- Pathogen Discovery Laboratory, Department of Virology, Institut Pasteur, Paris, France
| | - M Eloit
- Pathogen Discovery Laboratory, Department of Virology, Institut Pasteur, Paris, France
| | - I Sermet-Gaudelus
- Department of Pneumology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.,Reference Center Rare Diseases: cystic fibrosis, Paris, France.,INSERM U1151, Institut Necker - Enfants Malades, Université de Paris, Paris, France
| | - C Bodemer
- Department of Dermatology, Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.,Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.,INSERM U1163, Institut Imagine, Hôpital Universitaire Necker-Enfants Malades, Paris, France
| |
Collapse
|
12
|
Fertitta L, Hotz C, Sbidian E. Response to Marasca
et al
.’s letter about place of ultrasound in the evaluation of HS lesions. J Eur Acad Dermatol Venereol 2020; 34:e412-e413. [DOI: 10.1111/jdv.16359] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2020] [Accepted: 03/05/2020] [Indexed: 11/29/2022]
Affiliation(s)
- L. Fertitta
- Department of Dermatology Hôpital Henri Mondor Creteil France
| | - C. Hotz
- Department of Dermatology Hôpital Henri Mondor Creteil France
| | - E. Sbidian
- Department of Dermatology Hôpital Henri Mondor Creteil France
| |
Collapse
|
13
|
Fertitta L, Hotz C, Wolkenstein P, Méningaud JP, Sawan D, Hersant B, Sbidian E. Efficacy and satisfaction of surgical treatment for hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2019; 34:839-845. [PMID: 31799758 DOI: 10.1111/jdv.16135] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2019] [Accepted: 11/20/2019] [Indexed: 01/04/2023]
Abstract
BACKGROUND Surgery is a radical treatment for hidradenitis suppurativa (HS) and may be considered as the only one potentially curative. OBJECTIVES To characterize HS recurrence in patients after surgery and assess the risk factors of recurrence. METHODS We conducted a monocentric retrospective cohort study. All consecutive patients who had surgery (January 1, 2012 to March 31, 2017) were included. We estimated the rate of recurrence of HS lesions after surgery (<1 cm from the scar), and recurrence-associated factors were analysed by univariate then multivariate logistic regression, estimating odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS A total of 75 patients [median age 31.4 years (range 16-71); 36 females], corresponding to 115 interventions were included. The Hurley score at surgery was III for 70 (60%) patients. In total, 61/115 (53%) interventions involved wide excision and 50 (43%) limited local excision. The localizations were axillary folds (n = 46; 40%), buttocks (n = 15, 13%), genital area (n = 13; 11%), perineal area (n = 12; 10%) and inguinal folds (n = 18; 16%). We observed 11 (10%) complications and 40 (35%) recurrences. On multivariate analysis, probability of recurrence was associated with only one-stage surgical closure [OR 3.2 (95% CI 1.4-7.3), P = 0.005]. Overall, 44 (52%) patients were completely satisfied and 22 (26%) partially satisfied, and most (81%) considered the surgery the best treatment. CONCLUSIONS Hidradenitis suppurativa recurrence in our study was 35% and associated with one-stage surgical closures, but two-thirds of patients were satisfied with surgical treatment and would recommend surgery.
Collapse
Affiliation(s)
- L Fertitta
- Department of Dermatology, Hôpital Henri Mondor, Creteil, France
| | - C Hotz
- Department of Dermatology, Hôpital Henri Mondor, Creteil, France
| | - P Wolkenstein
- Department of Dermatology, Hôpital Henri Mondor, Creteil, France
| | - J P Méningaud
- Department of Plastic Surgery, Hôpital Henri Mondor, Creteil, France
| | - D Sawan
- Department of Plastic Surgery, Hôpital Henri Mondor, Creteil, France
| | - B Hersant
- Department of Plastic Surgery, Hôpital Henri Mondor, Creteil, France
| | - E Sbidian
- Department of Dermatology, Hôpital Henri Mondor, Creteil, France
| |
Collapse
|
14
|
Welfringer-Morin A, Moulin F, Drummond D, Oualha M, De Saint Blanquat L, Bendavid M, Aoust L, Belahda A, Kossorotoff M, Fertitta L, Bellon N, Hadj-Rabia S, Delacourt C, Leclerc-Mercier S, Frassati-Biaggi A, De Prost N, Oro S, Renolleau S, Bodemer C. Nécrolyse épidermique toxique de l’enfant : deux observations inhabituelles d’évolution fatale. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
15
|
Fertitta L, Welfringer-Morin A, Rigourd V, Jamet A, Hadj-Rabia S, Lesage F, Bodemer C. Neonatal staphylococcal scalded skin syndrome in a breastfed neonate. J Eur Acad Dermatol Venereol 2019; 34:e36-e38. [PMID: 31420893 DOI: 10.1111/jdv.15889] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- L Fertitta
- Department of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France
| | - A Welfringer-Morin
- Department of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France
| | - V Rigourd
- Breast Milk bank, Hôpital Universitaire Necker - Enfants Malades, Paris, France
| | - A Jamet
- Department of Bacteriology, Hôpital Universitaire Necker - Enfants Malades, Paris, France
| | - S Hadj-Rabia
- Department of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.,INSERM U1163, Institut Imagine, Hôpital Universitaire Necker - Enfants Malades, Paris, France
| | - F Lesage
- Department of Intensive Care, Hôpital Universitaire Necker - Enfants Malades, Paris, France
| | - C Bodemer
- Department of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Université de Paris AP-HP-5, Hôpital Universitaire Necker-Enfants Malades, Paris, France.,INSERM U1163, Institut Imagine, Hôpital Universitaire Necker - Enfants Malades, Paris, France
| |
Collapse
|
16
|
Fertitta L, Welfringer-Morin A, Rigourd V, Jamet A, Lesage F, Bodemer C. SSSS néonatal sur infection de lait maternel. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
17
|
Fertitta L, Bodemer C, Frassati-Biaggi A, Fraitag S, Leclerc-Mercier S. Pustulose ou folliculite à éosinophiles ? Étude histologique d’une entité plutôt confuse. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
18
|
Fertitta L, Fontbrune FSD, Battistella M, De Masson A, Bergeron A, Ranta D, Vignon-Pennamen MD, Bagot M, Bouaziz JD. Folliculotropic mycosis fungoides associated with GATA2 deficiency: a new skin manifestation. Br J Dermatol 2018; 179:1420-1421. [PMID: 30101490 DOI: 10.1111/bjd.17081] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
| | | | | | | | - A Bergeron
- Department of Pneumology, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France
| | - D Ranta
- Department of Haematology, CHRU de Nancy, Nancy, France
| | | | | | | |
Collapse
|
19
|
Fertitta L, Monsel G, Delaroche M, Fourniols E, Brossier F, Caumes E. Cutaneous melioidosis: two cases of chronic primary forms. J Eur Acad Dermatol Venereol 2018; 32:e270-e272. [PMID: 29356200 DOI: 10.1111/jdv.14800] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- L Fertitta
- Infectious Diseases Department, Pitié Salpétrière University Hospital, Paris, France
| | - G Monsel
- Infectious Diseases Department, Pitié Salpétrière University Hospital, Paris, France
| | - M Delaroche
- Infectious Diseases Department, Pitié Salpétrière University Hospital, Paris, France
| | - E Fourniols
- Orthopedia Department, Pitié Salpétrière University Hospital, Paris, France
| | - F Brossier
- Bacteriology Department, Pitié Salpétrière University Hospital, Paris, France
| | - E Caumes
- Infectious Diseases Department, Pitié Salpétrière University Hospital, Paris, France
| |
Collapse
|
20
|
Fertitta L, Orvain C, Kervevan J, Hotz C, Jean-Louis F, Aguilar P, Hersant B, Bosc R, Wolkenstein P, Lelievre JD, Boniotto M, Hüe S. Hidradénite suppurée : infiltration de cellules dendritiques plasmacytoïdes dans les lésions. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
21
|
Fertitta L, Noel N, Ackermann F, Lerolle N, Benoist S, Rocher L, Lambotte O. Pancréatite aiguë inaugurale d’une vascularite à IgA de l’adulte : une manifestation inhabituelle. Rev Med Interne 2017; 38:691-694. [DOI: 10.1016/j.revmed.2017.01.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2016] [Revised: 01/05/2017] [Accepted: 01/19/2017] [Indexed: 02/07/2023]
|
22
|
Fertitta L, Monsel G, de Laroche M, Fourniols É, Brossier F, Caumes É. Mélioïdose cutanée : une maladie rare à évoquer chez les voyageurs. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
23
|
Secor RM, Fertitta L. Vulvar vestibulitis syndrome. Nurse Pract Forum 1992; 3:161-8. [PMID: 1472890] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Vulvar Vestibulitis Syndrome (VVS) is a condition characterized by dyspareunia, introital erythema, and tenderness. A subset of vulvodynia, VVS may be acute or chronic. If acute, a specific underlying cause is often identified, and when properly treated the condition is likely to fully resolve. In contrast, chronic VVS is less well understood and is often multifactorial. Treatment is aimed at providing symptomatic relief and should begin with the least invasive approaches such as the use of topical xylocaine, oral antiviral therapy, acupuncture, and hypnotherapy. Interferon injections may be tried as last line medical therapy. Surgery has no role in treatment of acute VVS and is considered a last resort therapy for management of chronic VVS. Effort should be made to support the patient throughout the lengthy management process, encouraging patient participation, including negotiation of the treatment plan, and providing ongoing counselling and education.
Collapse
|
24
|
Hutchinson M, Fertitta L, Goldbaum B, Hamza M, Vanerian S, Isenstein L. Cervex-Brush and Cytobrush. Comparison of their ability to sample abnormal cells for cervical smears. J Reprod Med 1991; 36:581-6. [PMID: 1941800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
A study was designed to test specimen adequacy and the detection of disease using two new cervical cytologic sampling devices, the Cervex-Brush and Cytobrush plus a modified Ayre spatula. Two clinicians used each device at random. The laboratory was blind to the sampling method, and the results were compared with those from control samples (Ayre spatula with cotton swab or alone). The 567 test samples were compared with 569 age-matched control samples. The Cervex-Brush and Cytobrush plus spatula were comparable in detecting disease, and both were improvements over the control method. Both the Cervex-Brush and Cytobrush plus spatula produced more consistent good smear quality across the age range studied than did the control method, which resulted in a lower percentage of good-quality smears in older women. Use of the Cytobrush plus spatula and the control method produced smear results the quality of which varied considerably with each clinician.
Collapse
Affiliation(s)
- M Hutchinson
- Department of Pathology, New England Medical Center, Tufts University, Boston, Massachusetts 02111
| | | | | | | | | | | |
Collapse
|